126 related articles for article (PubMed ID: 30316357)
1. C3d Assay in Correlation With Single Antigen Bead Assay for Human Leukocyte Antigen Antibodies.
Ko SY; Lee W; Jung CW; Cho Y
Transplant Proc; 2018 Oct; 50(8):2354-2358. PubMed ID: 30316357
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
[TBL] [Abstract][Full Text] [Related]
3. Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.
Greenshields A; Bray RA; Gebel HM; Liwski RS
Hum Immunol; 2019 Jul; 80(7):468-477. PubMed ID: 31040048
[TBL] [Abstract][Full Text] [Related]
4. Determinants of C1q binding in the single antigen bead assay.
Schaub S; Hönger G; Koller MT; Liwski R; Amico P
Transplantation; 2014 Aug; 98(4):387-93. PubMed ID: 24918611
[TBL] [Abstract][Full Text] [Related]
5. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
[TBL] [Abstract][Full Text] [Related]
6. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays.
Navas A; Molina J; Agüera ML; Guler I; Jurado A; Rodríguez-Benot A; Alonso C; Solana R
Front Immunol; 2019; 10():1712. PubMed ID: 31428086
[TBL] [Abstract][Full Text] [Related]
8. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.
Zeevi A; Lunz J; Feingold B; Shullo M; Bermudez C; Teuteberg J; Webber S
J Heart Lung Transplant; 2013 Jan; 32(1):98-105. PubMed ID: 23142561
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Anti-HLA Antibodies of Highly Sensitized Patients by Single Antigen Bead and C1q Tests.
Ayna TK; Koçyİğİt AÖ; Soypaçaci Z; Tuğmen C; Pirim I
Transplant Proc; 2019 May; 51(4):1024-1026. PubMed ID: 31101164
[TBL] [Abstract][Full Text] [Related]
10. The ABCs (DRDQDPs) of the prozone effect in single antigen bead HLA antibody testing: Lessons from our highly sensitized patients.
Greenshields AL; Liwski RS
Hum Immunol; 2019 Jul; 80(7):478-486. PubMed ID: 31080010
[TBL] [Abstract][Full Text] [Related]
11. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.
Chen G; Sequeira F; Tyan DB
Hum Immunol; 2011 Oct; 72(10):849-58. PubMed ID: 21791230
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies.
Claisse G; Absi L; Cognasse F; Alamartine E; Mariat C; Maillard N
Hum Immunol; 2017 Apr; 78(4):336-341. PubMed ID: 28189573
[TBL] [Abstract][Full Text] [Related]
13. The correlation of results of panel reactive antibody, identification, and single antigen beads in detection of anti-HLA antibodies: Istanbul Faculty of Medicine, tissue typing laboratory experience.
Ciftci HS; Oguz FS; Cinar CK; Izgi DK
Transpl Immunol; 2023 Oct; 80():101891. PubMed ID: 37433395
[TBL] [Abstract][Full Text] [Related]
14. From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.
Claisse G; Mariat C; Maillard N
Clin Transpl; 2016; 32():153-160. PubMed ID: 28564533
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Complement-Binding Capacity of HLA Antibodies Based on Mean Fluorescence Intensity.
Zhao J; Fu YX; Yang T; Shen ZY; Wu CL
Transplant Proc; 2016; 48(6):2235-40. PubMed ID: 27569975
[TBL] [Abstract][Full Text] [Related]
16. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
18. Complement and Non-Complement Binding Anti-HLA Antibodies Are Differentially Detected with Different Antigen Bead Assays in Renal Transplant Recipients.
Ouranos K; Panteli M; Petasis G; Papachristou M; Iosifidou AM; Iosifidou MA; Anastasiou A; Samali M; Stangou M; Theodorou I; Lioulios G; Fylaktou A
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137802
[TBL] [Abstract][Full Text] [Related]
19. Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection.
Oh EJ; Park H; Park KU; Kang ES; Kim HS; Song EY
Ann Lab Med; 2015 May; 35(3):321-8. PubMed ID: 25932440
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
